OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Ejection Fraction Abnormal reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,213 reports · 43 co-occurring drugs

As of the last recalculation, Ejection Fraction Abnormal appears in 1,213 FAERS reports alongside 43 co-occurring drug terms. The strongest observed disproportionality signal is LIOTHYRONINE SODIUM (PRR 175.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Liothyronine Sodium83175.5177.2
Mometasone99100.7101.3
Sacubitril And Valsartan42897.297.6
Esomeprazole Magnesium Capsule, Delayed Release7087.888.2
Esomeprazole Magnesium Delayed Release Capsules7087.888.2
Esomeprazole Magnesium Dihydrate7087.487.8
Sodium Bicarbonate7458.158.3
Sodium Bicarbonate Injection,7458.158.3
Mometasone Furoate9542.442.5
Cyanocobalamin7541.641.7
Bupropion7631.231.2
Tramadol Hydrochloride6330.230.3
Trazodone Hydrochloride2528.028.0
Esomeprazole8926.526.5
Montelukast10322.922.9
Apixaban8322.822.8
Spironolactone15621.721.7
Budesonide6519.920.0
Torsemide3518.618.7
Sirolimus1418.018.0
Lapatinib1617.917.9
Melphalan2216.916.9
Ado-Trastuzumab Emtansine816.416.4
Trastuzumab6216.316.3
Eplerenone1216.216.2
Melphalan Hydrochloride2316.016.0
Sodium Chloride Tablet6415.715.7
Sodium Chloride Tablets6415.715.7
Sodium Chloride6514.914.9
Metoprolol Tartrate Injection14514.814.8
Vitamin C7314.414.5
Levothyroxine Sodium Anhydrous7914.414.4
Metoprolol16212.512.5
Acyclovir7612.112.1
Pertuzumab1811.511.5
Dabrafenib108.28.2
Carfilzomib138.08.0
Trametinib117.97.9
Fam-Trastuzumab Deruxtecan-Nxki46.86.8
Dofetilide46.66.6
Osimertinib126.56.5
Tafamidis45.85.8
Dasatinib104.64.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.